ID: ALA5291262

Max Phase: Preclinical

Molecular Formula: C14H12O4

Molecular Weight: 244.25

Associated Items:

Representations

Canonical SMILES:  Oc1cc2c(cc1O)-c1c(ccc(O)c1O)CC2

Standard InChI:  InChI=1S/C14H12O4/c15-10-4-3-7-1-2-8-5-11(16)12(17)6-9(8)13(7)14(10)18/h3-6,15-18H,1-2H2

Standard InChI Key:  AGMHXWUASVHTLZ-UHFFFAOYSA-N

Associated Targets(Human)

Alpha-synuclein 10960 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 244.25Molecular Weight (Monoisotopic): 244.0736AlogP: 2.27#Rotatable Bonds: 0
Polar Surface Area: 80.92Molecular Species: NEUTRALHBA: 4HBD: 4
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: 8.99CX Basic pKa: CX LogP: 2.97CX LogD: 2.96
Aromatic Rings: 2Heavy Atoms: 18QED Weighted: 0.54Np Likeness Score: 1.50

References

1. Bernardes G, Munir O, Krol ES..  (2023)  The effect of diphenylethane side-chain substituents on dibenzocyclohexadiene formation and their inhibition of α-synuclein aggregation in vitro.,  78  [PMID:36587551] [10.1016/j.bmc.2022.117147]

Source